A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for

Keiichi Hirose1, Akira Marui, Yoshio Arai

  • 1Department of Cardiovascular Surgery, Shizuoka Children's Hospital, Shizuoka, Japan.

Heart and Vessels
|July 27, 2007
PubMed

Insights

Sustained-release basic fibroblast growth factor (bFGF) enhanced tissue regeneration around implanted materials. This significantly reduced bacterial invasion, offering a novel strategy to prevent catheter-related infections.

Area of Science:

  • Biomaterials Science
  • Infectious Disease Research
  • Regenerative Medicine

Background:

  • Catheter-related infections are a serious complication caused by microbial invasion along implanted foreign materials.
  • Basic fibroblast growth factor (bFGF) is known for its potent mitogenic properties, promoting tissue growth and regeneration.

Purpose of the Study:

  • To investigate the efficacy of sustained-release basic fibroblast growth factor (bFGF) in preventing catheter-related bacterial invasion.
  • To evaluate the impact of bFGF on tissue regeneration and foreign material integration in vivo.

Main Methods:

  • Sterile Dacron sheets were implanted in mice and treated with either no treatment, gelatin hydrogel, free bFGF, or sustained-release bFGF.
  • Tissue integration was assessed via a detachment test measuring pull-out force.
  • Bacterial invasion was simulated using methicillin-resistant Staphylococcus aureus (MRSA) inoculation.

Main Results:

  • Sustained-release bFGF significantly increased the force required to detach the Dacron sheets compared to other groups.
  • Microscopic analysis revealed enhanced granulation tissue formation with abundant collagen and vessels in the bFGF-treated group.
  • The number of MRSA within the Dacron sheets was significantly lower in the sustained-release bFGF group.

Conclusions:

  • Pretreatment with sustained-release bFGF promotes robust tissue regeneration and integration of foreign materials.
  • This approach effectively reduces catheter-related bacterial invasion, demonstrating potential as an adjuvant therapy for infection prevention.

Related Concept Videos